Makoto Matsumoto Selected Research

Makoto Matsumoto Research Topics

Disease

15	Tuberculosis (Tuberculoses) 01/2018 - 09/2004
13	Infections 01/2022 - 09/2004
5	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 12/2020 - 01/2016
4	Inflammation (Inflammations) 01/2014 - 06/2002
3	Extensively Drug-Resistant Tuberculosis 01/2018 - 05/2009
3	Body Weight (Weight, Body) 01/2017 - 04/2007
2	Malaria 10/2017 - 01/2013
2	Necrosis 06/2017 - 03/2006
2	Mastocytosis 01/2014 - 07/2013
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Intracranial Vasospasm 12/2021
1	Poisoning 12/2021
1	Primary Headache Disorders 12/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Coccidiosis 10/2017
1	Toxoplasmosis 10/2017
1	Cryptosporidiosis 10/2017
1	Leishmaniasis 10/2017
1	Pleural Effusion (Pleural Effusions) 06/2017
1	Communicable Diseases (Infectious Diseases) 03/2017
1	Allergic Rhinitis 01/2017
1	AIDS-Related Complex (ARC) 01/2017
1	Hypersensitivity (Allergy) 01/2017
1	Rhinitis 01/2017
1	Sneezing 01/2017
1	Pulmonary Tuberculosis 11/2015
1	Latent Tuberculosis 11/2015
1	Coinfection 11/2015
1	Eosinophilia 01/2014
1	Nematode Infections 01/2014
1	Hyperplasia 01/2014
1	Diarrhea 07/2006
1	Vomiting 07/2006
1	Severe Acute Respiratory Syndrome 01/2006

Drug/Important Bio-Agent (IBA)

10	Pharmaceutical PreparationsIBA 01/2018 - 11/2006
8	OPC-67683IBA 12/2020 - 11/2006
7	VaccinesIBA 01/2013 - 03/2005
6	AntigensIBA 01/2017 - 01/2006
5	Proteins (Proteins, Gene)FDA Link 06/2017 - 01/2006
5	DNA (Deoxyribonucleic Acid)IBA 04/2007 - 09/2004
4	Immunoglobulin G (IgG)IBA 01/2017 - 07/2005
4	Immunoglobulin E (IgE)IBA 01/2017 - 07/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 06/2004
3	DNA VaccinesIBA 01/2011 - 04/2007
3	DNA-Binding Proteins (DNA Binding Protein)IBA 02/2010 - 09/2004
3	Interleukin-12 (IL 12)IBA 05/2009 - 03/2005
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 05/2009 - 03/2005
3	Liposomes (Liposome)IBA 05/2009 - 03/2005
2	Therapeutic UsesIBA 01/2022 - 01/2011
2	AntibodiesIBA 01/2017 - 11/2015
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 01/2006
2	Interleukin-5 (Interleukin 5)IBA 01/2014 - 02/2012
2	Interleukin-13IBA 01/2014 - 02/2012
2	Interleukin-33IBA 01/2014 - 02/2012
2	Isoniazid (Ftivazide)FDA LinkGeneric 08/2012 - 11/2006
2	CytokinesIBA 10/2007 - 06/2002
2	Rifampin (Rifampicin)FDA LinkGeneric 12/2006 - 11/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	QuinolonesIBA 01/2022
1	Tetrodotoxin (Tetradotoxin)IBA 12/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2020
1	ProdrugsIBA 01/2020
1	Coenzymes (Enzyme Cofactors)IBA 01/2020
1	5-deazaflavinIBA 01/2020
1	NitroreductasesIBA 01/2020
1	oxidized low density lipoproteinIBA 01/2018
1	prolyl T RNA synthetaseIBA 10/2017
1	EnzymesIBA 06/2017
1	Lactose FDA LinkGeneric 06/2017
1	InterferonsIBA 06/2017
1	NitroimidazolesIBA 03/2017
1	4-nitroimidazoleIBA 03/2017
1	lipoarabinomannan (LAM)IBA 01/2017
1	Mycobacterium tuberculosis antigensIBA 01/2017
1	AllergensIBA 01/2017
1	Clodronic Acid (Clodronate)IBA 01/2017
1	EndotoxinsIBA 01/2017
1	Histamine Antagonists (Antihistamines)IBA 01/2017
1	OvalbuminIBA 01/2017
1	Immune Sera (Antisera)IBA 10/2016
1	ChitinIBA 01/2014
1	Immunoglobulin M (IgM)IBA 07/2013
1	Cytidine DeaminaseIBA 07/2013
1	AerosolsIBA 01/2011
1	Antimicrobial PeptidesIBA 10/2007
1	ProstaglandinsIBA 10/2007
1	Ligases (Synthetase)IBA 10/2007
1	ChemokinesIBA 10/2007
1	CCAAT-Enhancer-Binding Protein-betaIBA 10/2007
1	BCG Vaccine FDA Link 04/2007
1	Ethambutol (Myambutol)FDA LinkGeneric 11/2006
1	Pyrazinamide FDA LinkGeneric 11/2006
1	Antimalarials (Antimalarial Agents)IBA 07/2006
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2006
1	Complementary DNA (cDNA)IBA 01/2006
1	A-Form DNA (A-DNA)IBA 03/2005
1	Hyaluronic Acid (Hyaluronan)IBA 09/2004
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2004

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2020
1	Drug Therapy (Chemotherapy) 08/2012